Caas Capital Management LP Evelo Biosciences, Inc. Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$9.43 - $16.6 $777,956 - $1.37 Million	-82,498 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $801,055 - $1.53 Million	82,498 New	82,498 $883,000
Q4 2020 Feb 12, 2021	SELL	$3.91 - $12.28 $128,009 - $402,034	-32,739 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$3.81 - $5.73 $351,514 - $528,655	-92,261 Reduced 73.81%	32,739 $173,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.12 $441,250 - $765,000	125,000 New	125,000 $613,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.